NCT01734018View on ClinicalTrials.gov

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Hepatitis B, Chronic
Trial Locations (2)

13353

Berlin

04103

Leipzig

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01734018 - An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B | Biotech Hunter | Biotech Hunter